Valuation: Vineet Laboratories Limited

Market Cap 558M 5.86M 5.26M 4.86M 4.4M 8.23M 8.32M 58.12M 23.15M 292M 21.99M 21.53M 927M P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 956M 10.03M 9M 8.32M 7.54M 14.08M 14.25M 99.5M 39.63M 500M 37.65M 36.85M 1.59B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
65.45%
Yield 2024 *
-
Yield 2025 -
27/10 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
26/08 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
22/07 Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026 CI
29/05 Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026 CI
14/02 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
07/02 Vineet Laboratories Limited Approves Appointment of Jasmin Kunal Tailor as Independent Director CI
17/12 Vineet Laboratories says rights issue price set at 30 rupees per share RE
27/11 Vineet Laboratories Gets Board Nod to Raise Up to INR300 Million via Rights Issue MT
27/11 Vineet Laboratories to raise funds up to 300 million rupees via rights issue RE
24/11 Vineet Laboratories to consider rights issue RE
08/11 Vineet Laboratories Limited Announces Resignation of Hari Priya Yerukalapudi as Independent Director, Effective November 08, 2025 CI
17/09/25 Vineet Laboratories Limited Approves the Appointment of Premananda Reddy Vennapusa as Non-Executive Director, Effective from September 15, 2025 CI
22/07/25 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
1 day-1.98%
1 week-5.16%
Current month-2.96%
1 month+2.07%
3 months-7.35%
6 months-1.04%
Current year-1.96%
1 week 34.38
Extreme 34.38
38.4
1 month 34.38
Extreme 34.38
41.3
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
92
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Director of Finance/CFO 76 01/01/2021
Human Resources Officer - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 57 10/11/2016
Director/Board Member 76 10/11/2016
Chairman 73 16/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.98%-5.16%-19.63%-30.85% 7.44M
+0.50%+1.38%+57.09%+129.96% 1,143B
+0.86%+5.14%+45.00%+86.15% 647B
-0.14%+0.42%+25.69%+105.85% 506B
-0.05%+1.73%+52.74%+67.74% 384B
-0.63%-5.97%+61.93%+37.06% 350B
+0.34%+1.84%+30.70%+54.27% 293B
-0.45%+1.19%+2.89%+26.08% 265B
+0.87%+3.08%+54.69%+72.74% 242B
+0.08%+3.67%+35.05%+107.78% 197B
Average -0.06%+0.81%+34.61%+65.68% 402.75B
Weighted average by Cap. +0.25%+1.55%+44.50%+89.02%

Financials

2024 2025
Net sales 1.51K 15.85 14.22 13.15 11.91 22.25 22.52 157.2 62.62 789.97 59.48 58.23 2.51K 769.53 8.08 7.25 6.7 6.07 11.34 11.48 80.13 31.92 402.68 30.32 29.68 1.28K
Net income 10.27M 108K 96.76K 89.46K 81.02K 151K 153K 1.07M 426K 5.37M 405K 396K 17.06M -202M -2.12M -1.9M -1.76M -1.59M -2.98M -3.01M -21.03M -8.37M -106M -7.96M -7.79M -335M
Net Debt 441M 4.63M 4.15M 3.84M 3.48M 6.49M 6.57M 45.89M 18.28M 231M 17.36M 17M 732M 397M 4.17M 3.74M 3.46M 3.13M 5.86M 5.93M 41.38M 16.48M 208M 15.66M 15.33M 660M
Projected Income Statement - Annual - Vineet Laboratories Limited
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
28/10/26 INR 36.06 -1.98% 122,009
27/10/26 INR 36.79 -1.50% 106,299
26/10/26 INR 37.35 +3.09% 259,400
23/10/26 INR 36.23 -2.58% 153,945
22/10/26 INR 37.19 -2.18% 56,953
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock